[Cancer of the prostate: therapeutic strategy in 1985]

After extensive staging, localized prostate carcinomas are treated by radical prostatectomy, external beam radiation therapy or interstitial radioactive implantation therapy combined or not with external radiation. For these patients, it is not demonstrated that adjuvant hormonotherapy increases survival duration. For metastatic carcinomas, orchiectomy or low dose of DES are possible. When carcinoma patients escape to endocrine treatment, there are given chemotherapy. Hormonal associations with central and peripheral action mechanisms could modify, in early future, present treatment options for advanced carcinomas.